Insider Transactions in Q2 2022 at Edgewise Therapeutics, Inc. (EWTX)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 21
2022
|
John R Moore General Counsel |
SELL
Open market or private sale
|
Direct |
31,078
-91.2%
|
$217,546
$7.29 P/Share
|
|
Jun 21
2022
|
John R Moore General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
31,078
+39.51%
|
$31,078
$1.32 P/Share
|
|
Jun 17
2022
|
John R Moore General Counsel |
SELL
Open market or private sale
|
Direct |
22,127
-88.06%
|
$132,762
$6.62 P/Share
|
|
Jun 17
2022
|
John R Moore General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
22,127
+46.83%
|
$22,127
$1.93 P/Share
|
|
Jun 16
2022
|
John R Moore General Counsel |
SELL
Open market or private sale
|
Direct |
14,722
-83.07%
|
$88,332
$6.17 P/Share
|
|
Jun 16
2022
|
John R Moore General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
14,722
+45.38%
|
$14,722
$1.93 P/Share
|
|
Jun 15
2022
|
John R Moore General Counsel |
SELL
Open market or private sale
|
Direct |
18,660
-44.23%
|
$111,960
$6.11 P/Share
|
|
Jun 15
2022
|
John R Moore General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
18,660
+24.4%
|
$18,660
$1.32 P/Share
|
|
Jun 14
2022
|
John R Moore General Counsel |
SELL
Open market or private sale
|
Direct |
3,628
-54.74%
|
$21,768
$6.02 P/Share
|
|
Jun 14
2022
|
John R Moore General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
3,628
+35.37%
|
$0
$0.71 P/Share
|
|
Jun 13
2022
|
John R Moore General Counsel |
SELL
Open market or private sale
|
Direct |
4,093
-57.7%
|
$24,558
$6.01 P/Share
|
|
Jun 13
2022
|
John R Moore General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
4,093
+36.59%
|
$0
$0.71 P/Share
|
|
Jun 10
2022
|
John R Moore General Counsel |
SELL
Open market or private sale
|
Direct |
7,125
-70.37%
|
$42,750
$6.05 P/Share
|
|
Jun 10
2022
|
John R Moore General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
7,125
+41.3%
|
$0
$0.71 P/Share
|
|
Jun 09
2022
|
John R Moore General Counsel |
SELL
Open market or private sale
|
Direct |
7,615
-71.74%
|
$45,690
$6.49 P/Share
|
|
Jun 09
2022
|
John R Moore General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
7,615
+41.77%
|
$0
$0.71 P/Share
|
|
Jun 08
2022
|
John R Moore General Counsel |
SELL
Open market or private sale
|
Direct |
12,566
-80.73%
|
$75,396
$6.63 P/Share
|
|
Jun 08
2022
|
John R Moore General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
12,566
+44.67%
|
$0
$0.71 P/Share
|
|
Jun 07
2022
|
John R Moore General Counsel |
SELL
Open market or private sale
|
Direct |
18,123
-54.8%
|
$108,738
$6.61 P/Share
|
|
Jun 07
2022
|
John R Moore General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
18,123
+32.83%
|
$18,123
$1.32 P/Share
|
|
Jun 06
2022
|
John R Moore General Counsel |
SELL
Open market or private sale
|
Direct |
13,934
-82.28%
|
$83,604
$6.03 P/Share
|
|
Jun 06
2022
|
John R Moore General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
13,934
+45.14%
|
$13,934
$1.93 P/Share
|
|
Jun 03
2022
|
John R Moore General Counsel |
SELL
Open market or private sale
|
Direct |
15,230
-83.54%
|
$91,380
$6.05 P/Share
|
|
Jun 03
2022
|
John R Moore General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
15,230
+45.52%
|
$15,230
$1.93 P/Share
|
|
May 23
2022
|
R Michael Carruthers Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,000
+42.86%
|
$0
$0.71 P/Share
|
|
May 18
2022
|
Peter A. Thompson |
BUY
Open market or private purchase
|
Indirect |
138,000
+1.01%
|
$966,000
$7.21 P/Share
|
|
May 18
2022
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
138,000
+1.01%
|
$966,000
$7.21 P/Share
|
|
May 16
2022
|
John R Moore General Counsel |
SELL
Open market or private sale
|
Direct |
10,800
-78.26%
|
$75,600
$7.42 P/Share
|